OPIANT PHARMACEUTICALS, INC. Quarterly Return On Assets in % from Q1 2012 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2022.
  • Opiant Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2022 was -59.8 %, a 2480% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Return On Assets for 2021 was 4.63 %.
  • Opiant Pharmaceuticals, Inc. annual Return On Assets for 2020 was -4.12 %, a 112% decline from 2019.
  • Opiant Pharmaceuticals, Inc. annual Return On Assets for 2019 was 33.9 %.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -59.8 -62.3 -2480% Jul 1, 2022 Sep 30, 2022
Q2 2022 -31.8 -29.8 -1485% Apr 1, 2022 Jun 30, 2022
Q1 2022 -9.69 -3.68 -61.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 4.63 +8.75 Oct 1, 2021 Dec 31, 2021
Q3 2021 2.51 +2.78 Jul 1, 2021 Sep 30, 2021
Q2 2021 -2.01 -26.7 -108% Apr 1, 2021 Jun 30, 2021
Q1 2021 -6.01 -37.3 -119% Jan 1, 2021 Mar 31, 2021
Q4 2020 -4.12 -38 -112% Oct 1, 2020 Dec 31, 2020
Q3 2020 -0.27 -3.41 -109% Jul 1, 2020 Sep 30, 2020
Q2 2020 24.7 +62 Apr 1, 2020 Jun 30, 2020
Q1 2020 31.3 +85.8 Jan 1, 2020 Mar 31, 2020
Q4 2019 33.9 +131 Oct 1, 2019 Dec 31, 2019
Q3 2019 3.14 +45.4 Jul 1, 2019 Sep 30, 2019
Q2 2019 -37.3 +39.6 +51.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -54.5 +15.7 +22.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -97.2 -75.6 -349% Oct 1, 2018 Dec 31, 2018
Q3 2018 -42.2 -88.6 -191% Jul 1, 2018 Sep 30, 2018
Q2 2018 -76.9 -161 -191% Apr 1, 2018 Jun 30, 2018
Q1 2018 -70.2 -163 -176% Jan 1, 2018 Mar 31, 2018
Q4 2017 -21.6 -216 -111% Oct 1, 2017 Dec 31, 2017
Q3 2017 46.4 -94.6 -67.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 84.2 +591 Apr 1, 2017 Jun 30, 2017
Q1 2017 92.4 +794 Jan 1, 2017 Mar 31, 2017
Q4 2016 194 +1.34K Nov 1, 2016 Jan 31, 2017
Q3 2016 141 +2.12K Aug 1, 2016 Oct 31, 2016
Q2 2016 -507 +89.8 +15% May 1, 2016 Jul 31, 2016
Q1 2016 -701 +143 +17% Feb 1, 2016 Apr 30, 2016
Q4 2015 -1.14K -159 -16.2% Nov 1, 2015 Jan 31, 2016
Q3 2015 -1.98K -418 -26.7% Aug 1, 2015 Oct 31, 2015
Q2 2015 -597 +2.8K +82.4% May 1, 2015 Jul 31, 2015
Q1 2015 -845 +1.19K +58.4% Feb 1, 2015 Apr 30, 2015
Q4 2014 -983 +683 +41% Nov 1, 2014 Jan 31, 2015
Q3 2014 -1.56K +616 +28.2% Aug 1, 2014 Oct 31, 2014
Q2 2014 -3.4K -964 -39.6% May 1, 2014 Jul 31, 2014
Q1 2014 -2.03K +2.17K +51.7% Feb 1, 2014 Apr 30, 2014
Q4 2013 -1.67K +12.2K +88% Nov 1, 2013 Jan 31, 2014
Q3 2013 -2.18K +15.4K +87.6% Aug 1, 2013 Oct 31, 2013
Q2 2013 -2.43K +21.7K +89.9% May 1, 2013 Jul 31, 2013
Q1 2013 -4.2K +18.4K +81.5% Feb 1, 2013 Apr 30, 2013
Q4 2012 -13.8K Nov 1, 2012 Jan 31, 2013
Q3 2012 -17.6K Aug 1, 2012 Oct 31, 2012
Q2 2012 -24.1K May 1, 2012 Jul 31, 2012
Q1 2012 -22.6K Feb 1, 2012 Apr 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.